Gene therapies, today and tomorrow
By supporting and encouraging evidence-based access to gene therapy, payers and other segments of U.S. society will be positioned to benefit from future advancements and biopharmaceutical breakthrough...
Read MoreUnderstanding hereditary angioedema (HAE)
Breaking down what plan sponsors should know about HAE, its challenges and therapies.
Read MoreThe importance of a clinical-first approach to formulary development
The clinical efficacy of a drug must always take priority over any other considerations when developing formularies.
Read MoreThe benefits of timely and actionable specialty reporting
A comprehensive suite of reporting tools—and the right specialty partner to interpret data—can be invaluable for plan sponsors.
Read MorePharmacy in Focus
See the future taking shape in pharmacy and how you can capitalize and prepare for 2024 and beyond.
Read MoreThe importance of utilization management within the medical benefit
The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.
Read More